isoxazoles has been researched along with Hematologic Diseases in 11 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 6 (54.55) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (18.18) | 29.6817 |
2010's | 3 (27.27) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Jia, Y; Miao, H; Wang, L; Yang, Y; Zhang, XY; Zhou, YS | 1 |
Chen, B; Huang, WH; Lee, AR; Media, J; Shaw, J; Valeriote, FA | 1 |
Suzuki, Y | 1 |
Sugii, S | 1 |
Saito, E; Suwa, A; Suzuki, Y; Wakabayashi, T | 1 |
Cripps, C; Eisenhauer, E; Fields, AL; Maroun, JA; Pater, JL; Stewart, DJ | 1 |
Eisenhauer, E; Maksymiuk, A; Maroun, JA; Pater, J; Stewart, DJ; Young, V | 1 |
Birch, R; Greco, A; Johnson, R; Kramer, BS; Prestridge, K | 1 |
Chang, YC; Falkson, G; Knuiman, MW; Pandya, KJ; Skeel, RT; Willson, JK; Wolter, JM | 1 |
Booth, BW; Budman, D; Ellison, RR; Khojasteh, A; Korzun, AH; Weiss, RB; Wood, W | 1 |
Blessing, JA; Buchsbaum, HJ; DiSaia, PJ; McGuire, WP | 1 |
2 review(s) available for isoxazoles and Hematologic Diseases
Article | Year |
---|---|
[Adverse effects of DMARDs in treatment of rheumatoid arthritis].
Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Female; Gold Sodium Thiomalate; Hematologic Diseases; Humans; Isoxazoles; Kidney Diseases; Leflunomide; Lung Diseases, Interstitial; Male; Methotrexate; Reproduction; Sulfasalazine | 2005 |
[Adverse effects of conventional DMARDs and biologic DMARDs].
Topics: Antibodies, Monoclonal; Antirheumatic Agents; Chemical and Drug Induced Liver Injury; Cysteine; Drug Eruptions; Drug Hypersensitivity; Hematologic Diseases; Humans; Immune System Diseases; Infliximab; Isoxazoles; Kidney Diseases; Leflunomide; Lung Diseases; Methotrexate | 2007 |
3 trial(s) available for isoxazoles and Hematologic Diseases
Article | Year |
---|---|
Phase II evaluation of acivicin in lung cancer: a Southeastern Cancer Study Group Trial.
Topics: Antibiotics, Antineoplastic; Carcinoma, Bronchogenic; Central Nervous System Diseases; Clinical Trials as Topic; Drug Evaluation; Hematologic Diseases; Humans; Isoxazoles; Lung Neoplasms; Oxazoles | 1986 |
Phase II clinical trial of acivicin in advanced breast cancer: an Eastern Cooperative Oncology Group Study.
Topics: Antibiotics, Antineoplastic; Breast Neoplasms; Central Nervous System Diseases; Clinical Trials as Topic; Drug Evaluation; Female; Gastrointestinal Diseases; Hematologic Diseases; Humans; Isoxazoles; Middle Aged; Neoplasm Metastasis; Oxazoles | 1986 |
Phase II trial of acivicin in advanced breast carcinoma: a Cancer and Leukemia Group B Study.
Topics: Adenocarcinoma; Aged; Antibiotics, Antineoplastic; Brain Diseases; Breast Neoplasms; Clinical Trials as Topic; Drug Evaluation; Female; Hematologic Diseases; Humans; Isoxazoles; Middle Aged; Neoplasm Metastasis; Oxazoles | 1986 |
6 other study(ies) available for isoxazoles and Hematologic Diseases
Article | Year |
---|---|
[Clinical characteristics of 4 cases of scleritis associated with systemic lupus erythematosus].
Topics: Adrenal Cortex Hormones; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Antinuclear; Arthritis; Cyclophosphamide; Disease Progression; Female; Hematologic Diseases; Humans; Isoxazoles; Leflunomide; Lung Diseases, Interstitial; Lupus Erythematosus, Systemic; Lupus Nephritis; Male; Middle Aged; Pain; Prognosis; Raynaud Disease; Recurrence; Scleritis; Serositis; Treatment Outcome; Triamcinolone Acetonide; Uveitis; Vision Disorders | 2016 |
The small-molecule TNF-alpha modulator, UTL-5g, reduces side effects induced by cisplatin and enhances the therapeutic effect of cisplatin in vivo.
Topics: Animals; Antineoplastic Agents; Blood Urea Nitrogen; Cell Line, Tumor; Chemical and Drug Induced Liver Injury; Cisplatin; Colonic Neoplasms; Female; Hematologic Diseases; Humans; Isoxazoles; Kidney Diseases; Lethal Dose 50; Male; Mice; Mice, Inbred ICR; Mice, SCID; Platelet Count; Toxicity Tests, Acute; Tumor Necrosis Factor-alpha | 2011 |
[Anti-rheumatic drugs].
Topics: Antirheumatic Agents; Cysteine; Hematologic Diseases; Humans; Hypersensitivity; Infections; Isoxazoles; Kidney Diseases; Leflunomide; Liver Neoplasms; Lung Diseases; Methotrexate | 2012 |
Phase II study of acivicin in colorectal carcinoma: a National Cancer Institute of Canada study.
Topics: Adenocarcinoma; Adult; Aged; Antibiotics, Antineoplastic; Central Nervous System Diseases; Colonic Neoplasms; Drug Administration Schedule; Drug Evaluation; Female; Hematologic Diseases; Humans; Infusions, Parenteral; Isoxazoles; Male; Middle Aged; Oxazoles; Rectal Neoplasms | 1984 |
Phase II study of acivicin in non-small cell lung cancer: a National Cancer Institute of Canada Study.
Topics: Adult; Aged; Antibiotics, Antineoplastic; Canada; Carcinoma, Non-Small-Cell Lung; Cognition Disorders; Drug Evaluation; Female; Hematologic Diseases; Humans; Isoxazoles; Lung Neoplasms; Male; Middle Aged; Oxazoles | 1986 |
Phase II trial of acivicin in patients with advanced epithelial ovarian carcinoma. A Gynecologic Oncology Group Study.
Topics: Adult; Antibiotics, Antineoplastic; Carcinoma, Squamous Cell; Dose-Response Relationship, Drug; Drug Evaluation; Female; Hematologic Diseases; Humans; Isoxazoles; Middle Aged; Nervous System Diseases; Ovarian Neoplasms; Oxazoles | 1986 |